×

Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression

  • US 6,180,403 B1
  • Filed: 10/28/1999
  • Issued: 01/30/2001
  • Est. Priority Date: 10/28/1999
  • Status: Expired due to Fees
First Claim
Patent Images

1. An antisense compound 8 to 30 nucleobases in length targeted to nucleotides 2911 through 2930, nucleotides 2641 through 2660 or nucleotides 2681 through 2700 of a 3′

  • -untranslated region, nucleotides 2770 through 2603 of a stop codon region, nucleotides 131 through 150, nucleotides 2471 through 2490 or nucleotides 2531 through 2570 of a coding region, or nucleotides 114 through 133 of an AUG codon region of human TNF-α

    converting enzyme SEQ ID NO;

    1, wherein said antisense compound inhibits expression of human TNF-α

    converting enzyme.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×